Concepedia

Publication | Closed Access

A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study

DOI

24

Citations

18

References

2014

Year

Jiao Yang, Carlos Vallarino, Morgan Bron, Alfonso Pérez, Huifang Liang, Guiandre Joseph, Shawn Yu
Current Medical Research and Opinion

Abstract

PIO was associated with a lower risk of all-cause mortality than INS.

References

YearCitations

Page 1